Am J Transplant, Volume 20, Suppl 3 Archives - Page 219 of 223 - ATC Abstracts

2020 American Transplant Congress
Serum Osteopontin Level is Negatively Associated with Vascular Reactivity Index by Digital Thermal Monitoring in Kidney Transplant Patients
B. Hsu¹, Y. Lai¹, M. Lee²
¹Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, ²Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
*Purpose: Osteopontin (OPN) is a potent inhibitor of mineralization and is a potent inducible inhibitor of vascular calcification. Studies in patients noted elevated levels of…
2020 American Transplant Congress
Facebunk: Does Social Media Have a Positive Impact on Living Kidney Donation
E. K. Venniro¹, R. Kashyap², J. G. Taylor¹
¹Nephrology, University of Rochester Medical Center, Rochester, NY, ²Surgery, University of Rochester Medical Center, Rochester, NY
*Purpose: More kidney transplant recipients are reaching out beyond their immediate contacts in order to find potential living donors. In addition, transplant centers and organizations…
2020 American Transplant Congress
Effect of Cold Ischemia Time on Long-Term Graft Survival of Post-One Year Survivor Deceased Donor Kidney Transplant Recipients
B. Murthy¹, H. Nguyen², A. Rana¹, A. Awan¹, C. Van Buren³, J. Goss¹
¹Baylor College of Medicine, Houston, TX, ²University of Texas Medical Branch, Galveston, TX, ³University of Texas Houston Medical School, Houston, TX
*Purpose: Prolonged cold ischemia time (CIT) is known to adversely affect short-term graft survival among renal allografts. However, its effect on long-term graft survival is…
2020 American Transplant Congress
Can HLA-DQ Molecular Mismatch Analysis Be Used to Predict Generation of De Novo Donor-Specific Antibody at an Individual Patient Level?
D. Pinelli¹, M. Casillas Abundis¹, R. Hod Dvorai², H. McDowell¹, A. R. Tambur¹
¹Northwestern University, Chicago, IL, ²SUNY Upstate Medical University, Syracuse, NY
*Purpose: De novo donor-specific antibodies (dnDSA), especially to HLA-DQ, are one of the leading causes of late kidney graft failure. Many investigators have attempted to…
2020 American Transplant Congress
Association between Longer Hospitalization and Development of De Novo Donor Specific Antibody in Simultaneous Liver-Kidney Transplant Recipients
M. Yazawa¹, O. Cseprekal², R. A. Helmick¹, M. Talwar¹, V. Balaraman¹, P. S. Podila³, S. Fossey⁴, S. K. Satapathy⁵, J. D. Eason¹, M. Z. Molnar¹
¹James D. Eason Transplant Institute, Methodist University Hospital, Memphis, TN, ²Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary, ³Faith & Health Division, Methodist Le Bonheur Healthcare, Memphis, TN, ⁴Transplant Immunology Laboratory, DCI Inc., Nashville, TN, ⁵Sandra Atlas Bass Center for Liver Diseases & Transplantation, Northshore University Hospital/Northwell Health, Manhasset, NY
*Purpose: De novo Donor Specific Antibodies (DSA) are considered a risk factor for worsening kidney allograft outcomes in recipients after simultaneous liver-kidney transplantation (SLK). No…
2020 American Transplant Congress
Evolving Trends in Simultaneous Liver Kidney Transplant (SLKT) – Results from the US SLKT Consortium
G. Cullaro¹, J. Jo², J. Rassiwala², L. Van Wagner², R. Wong³, J. C. Lai³, J. Magee⁴, A. Schluger¹, P. Barman⁵, Y. Patel⁵, K. Walters⁶, S. Biggins⁶, P. Sharma⁴, E. C. Verna¹
¹New York Presbyterian, New York, NY, ²Northwestern University, Chicago, IL, ³UCSF, San Francisco, CA, ⁴University of Michigan, Ann Arbor, MI, ⁵Duke University, Durham, NC, ⁶University of Washington, Seattle, WA
*Purpose: The utilization of SLKT in the United States is rising in the MELD era. We aimed to understand the contemporary changes in characteristics and…
2020 American Transplant Congress
Multifactorial Effect of Hepatocyte Growth Factor (HGF) on the Microscopic Regeneration of Liver Allograft in Recipients Who Underwent Transplantation from Living Donors
B. H. Ozdemir¹, G. Ozgun¹, A. Yucel Polat¹, M. Haberal²
¹Pathology, Baskent University, Ankara, Turkey, ²Department of General Surgery, Division of Transplantation, Baskent University, Ankara, Turkey
*Purpose: Although partial liver allografts from living donors have near-complete regeneration of their liver volumes within weeks after transplantation, the microscopic range of regeneration is…
2020 American Transplant Congress
Liver Transplantation in Locally Unresectable, Undifferentiated Embryonal Cell Sarcoma
B. I. Babu, D. L. Bigam, K. Z. Dajani, J. A. Shapiro, N. Kneteman
General Surgery ( HPB & Transplant), University of Alberta Hospital, Edmonton, AB, Canada
*Purpose: Undifferentiated Embryonal Cell Sarcoma (UESL) of the liver is the third most common malignant liver disease of childhood presenting as a rapidly enlarging intra-abdominal…
2020 American Transplant Congress
Brincidofovir for Treatment of Disseminated Human Adenovirus Infection in Pediatric Solid Organ Transplant Recipients
J. Londeree¹, R. Garro¹, R. Romero², R. George¹, P. Winterberg¹, R. Liverman³, A. Serluco³, S. Shin¹, I. Yildirim⁴
¹Pediatric Nephrology, Emory, Atlanta, GA, ²Pediatric Hepatology and Gastroenterology, Emory, Atlanta, GA, ³Pharmacy, Children's Healthcare of Atlanta, Atlanta, GA, ⁴Pediatric Infectious Disease, Emory, Atlanta, GA
*Purpose: Brincidofovir (BCV) is an investigational antiviral drug with potency against Human Adenovirus (HAdV). We describe four cases of disseminated HAdV infection treated with (BCV)…
2020 American Transplant Congress
Effectiveness and Tolerability of Cidofovir for the Management of BK Viremia in Kidney Transplant Recipients
M. Thornberg¹, J. Hedvat¹, N. Lange¹, C. Brennan², D. Salerno¹, D. Tsapepas²
¹NewYork-Presbyterian Hospital, Department of Pharmacy, New York, NY, ²Columbia Irving University Medical Center, Department of Transplant Surgery, New York, NY
*Purpose: BK viremia (BKV) is a common complication after kidney transplantation (KT) that often leads to graft dysfunction and loss. Without consensus management guidelines and…